Eagle Pharmaceuticals, Inc. ( EGRX) - Key Metrics
EGRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q2 | $4.94 | $0.39 | -$0.01 | -$0.01 |
| 2023Q1 | $5.08 | $0.44 | -$2.57 | -$2.57 |
| 2022Q4 | $4.66 | $0.63 | $2.89 | $2.88 |
| 2022Q3 | $5.01 | -$0.27 | -$1.01 | -$1.01 |
| 2022Q2 | $5.78 | -$0.74 | $3.35 | $3.35 |
EGRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q2 | ? | 12.32 |
| 2023Q1 | ? | 16.11 |
| 2022Q4 | ? | 11.65 |
| 2022Q3 | ? | -24.76 |
| 2022Q2 | ? | -15.09 |
EGRX
Price: $0.46
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 2.14
Exchange: OEM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 130600
Ebitda: 25.9 millionMarket Capitalization: 6.2 million